Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Professional Posters
All Days
Mon, Dec 5
Tue, Dec 6
Professional Posters
Type here to filter the list
Monday, December 5, 2022
2:00 PM – 3:30 PM
(4-028) Analysis of Factors Affecting Medication Adherence of Geriatric Outpatients Using the Self-reported Questionnaire
Favorite
2:00 PM – 3:30 PM
(4-066) Analysis of Unpredictable Adverse Drug Reaction in Elderly Patients and Drug Assessment
Favorite
2:00 PM – 3:30 PM
(4-018) Application of a Common Bioassay to Measure Deactivation of Beta-lactam Antibiotics
Favorite
2:00 PM – 3:30 PM
(4-033) Assessing awareness and Implementation of Herpes Zoster Vaccine Recommendations by Subspecialists in the United States
Favorite
2:00 PM – 3:30 PM
(4-044) Biosimilar Uptake and Cost Savings Analysis Before and After Implementation of a Pharmacist-driven Substitution Program Within a National Community Oncology Network
Favorite
2:00 PM – 3:30 PM
(4-046) Budget Impact Analysis and Cost Savings of Trastuzumab Biosimilar for the Treatment of Breast Cancer at a Tertiary Cancer Center in the United Arab Emirates
Favorite
2:00 PM – 3:30 PM
(4-007) Characterization of the New Orleans Syringe Access Program (NOSAP) Participants During the Initial Months of the Coronavirus Disease 2019 (COVID-19) Naloxone Education and Distribution Services
Favorite
2:00 PM – 3:30 PM
(4-026) Climate Change and Environmental Sustainability Actions of the Pharmaceutical Industry
Favorite
2:00 PM – 3:30 PM
(4-025) Clinical Management of Acute Agitation in Patients with Schizophrenia or Bipolar Disorder in Emergency Departments in the United States – a Retrospective Chart Review
Favorite
2:00 PM – 3:30 PM
(4-035) Clostridioides Difficile: A Recurrent Infection with Broad Economic Consequences for US Hospitals
Favorite
2:00 PM – 3:30 PM
(4-030) Collaboration Between a Family Medicine Clinic and Specialty Pharmacy to Administer Vaccines Under Medicare Part D During Home Based Primary Care Visits
Favorite
2:00 PM – 3:30 PM
(4-005) Correction of Warfarin Coagulopathy for Non-bleeding Patients in the Outpatient Setting at an Ambulatory Care Organization: Application of Vitamin K Guidance
Favorite
2:00 PM – 3:30 PM
(4-059) Developing a Virtual Formulary Education Program for Fifth-year Pharmacy Students During an Experiential Hospital Practice Training in an Academic Teaching Hospital in Japan
Favorite
2:00 PM – 3:30 PM
(4-057) Development and Accreditation of a Pharmacy Technician Training Program Within an Academic Healthcare System
Favorite
2:00 PM – 3:30 PM
(4-064) Development and Implementation of a Multimodal Propofol Storage Security Plan at a Large Health System
Favorite
2:00 PM – 3:30 PM
(4-038) Development of Best Practices for Smart Pump Drug Library Pertaining to Neonatal and Infant Continuous Infusions
Favorite
2:00 PM – 3:30 PM
(4-016) Does Focused Education on the Use of Proton Pump Inhibitors (PPIs) Reduce the Incidence of Acute Upper Gastrointestinal Bleeding (aUGIB) in Patients on Antithrombotic Therapy?
Favorite
2:00 PM – 3:30 PM
(4-032) Efficacy and Safety of Investigational Microbiota-based Live Biotherapeutic RBX2660 in Individuals with Recurrent Clostridioides difficile Infection from 5 Prospective Clinical Studies: An Update
Favorite
2:00 PM – 3:30 PM
(4-020) Establishing a Rifaximin Criteria for Use Protocol for Hepatic Encephalopathy
Favorite
2:00 PM – 3:30 PM
(4-042) Evaluating the Use of Blinatumomab Use in a Lebanese Tertiary Care Teaching Hospital
Favorite
2:00 PM – 3:30 PM
(4-068) Evaluation a Tetanus Immunization Screening Program Implementation in the Emergency Room Department of a Rural Medical Center
Favorite
2:00 PM – 3:30 PM
(4-045) Evaluation of a Fixed-dose Rasburicase Protocol for Treatment of Hyperuricemia at a Community Medical Center
Favorite
2:00 PM – 3:30 PM
(4-013) Evaluation of Direct Oral Anticoagulant Use Following Surgical Bioprosthetic Valve Replacement
Favorite
2:00 PM – 3:30 PM
(4-062) Evaluation of Door-to-needle Times for Intravenous Tissue Plasminogen Activator Before and After the Implementation of an Updated Interdisciplinary Code Stroke Process
Favorite
2:00 PM – 3:30 PM
(4-073) Evaluation of Perceived Stress and Lifestyle Choices Among U.S. Pharmacy Students at the Beginning of the COVID-19 Pandemic
Favorite
2:00 PM – 3:30 PM
(4-040) Exploratory Study on Effect of Repackaging Intravenous Cetirizine Hydrochloride Solution into Syringes on Drug Stability and Microbial Challenge Hold Time
Favorite
2:00 PM – 3:30 PM
(4-041) Extended Dating of IV Bags Utilizing Low Density Polyethylene Overwrap
Favorite
2:00 PM – 3:30 PM
(4-008) Financial Reimbursement and Productivity Metrics for Pharmacist-led Chronic Care Management Services in Rural Practice Settings
Favorite
2:00 PM – 3:30 PM
(4-051) Gastrointestinal Adverse Effects Associated with the Use of Intravenous Oliceridine Compared to Intravenous Hydromorphone or Fentanyl in Acute Pain Management Utilizing Indirect Treatment Comparison Methods
Favorite
2:00 PM – 3:30 PM
(4-009) Glycemic Impact of Janus Kinase Inhibitors in Diabetic Patients with Immune-mediated Rheumatic Diseases
Favorite
2:00 PM – 3:30 PM
(4-023) High Dose Epoetin Alpha in Jehovah’s Witness Patients with Critically Low Hemoglobin Levels
Favorite
2:00 PM – 3:30 PM
(4-029) Hospital at Home: Evidence to Support the Use of a Home Infusion Pharmacy
Favorite
2:00 PM – 3:30 PM
(4-036) Impact of a Ceftolozane/tazobactam Shortage in a Long-term Acute Care Hospital System
Favorite
2:00 PM – 3:30 PM
(4-063) Impact of a Pharmacist-led Transgender Men Health Education Group on Gender-affirming Hormone Therapy and Mental Health Disparities Among Veterans
Favorite
2:00 PM – 3:30 PM
(4-047) Impact of a Pharmacy Diversion Detection Program for Controlled Substance Use in Procedural Areas
Favorite
2:00 PM – 3:30 PM
(4-061) Impact of Latent Tuberculosis Treatment and Psychiatric Medication Interactions in a Long-term Psychiatric Facility
Favorite
2:00 PM – 3:30 PM
(4-001) Impact of Par Adjustments on Inventory Turnover Ratios at an Ambulatory Infusion Center
Favorite
2:00 PM – 3:30 PM
(4-010) Implementation and Outcomes of a Collaborative Drug Therapy Management Program in a Large Public Health Care System in the United States
Favorite
2:00 PM – 3:30 PM
(4-034) Implementation of a Restricted Antimicrobial Review Process Within a Long-term Acute Care Hospital
Favorite
2:00 PM – 3:30 PM
(4-002) Implementation of Centralized Product Defect Reporting for Cost Recovery Across Campuses
Favorite
2:00 PM – 3:30 PM
(4-065) Implementation of Outpatient COVID-19 Therapeutic Prophylaxis, and Treatments at a Mid-size Community Hospital
Favorite
2:00 PM – 3:30 PM
(4-055) Implementation of Reformatted Titration Orders to Comply with Joint Commission’s Medication Management (MM) Chapter MM.04.01.01
Favorite
2:00 PM – 3:30 PM
(4-015) Incidence of Alteplase Utilization for Central Venous Access De-clotting in Patients with Active COVID-19
Favorite
2:00 PM – 3:30 PM
(4-022) Interventions to Improve Methylprednisolone Injection Use in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
Favorite
2:00 PM – 3:30 PM
(4-071) Management of Patients with Multiple Sclerosis Within Health-system Specialty Pharmacies: Patient Reported Outcomes
Favorite
2:00 PM – 3:30 PM
(4-058) Mentoring Program for Hospital Pharmacists Involved in Pharmaceutical Management: Assessment of the First Cohort
Favorite
2:00 PM – 3:30 PM
(4-012) Metoprolol and CYP2D6: A Retrospective Cohort Study Evaluating Genotype-based Outcomes
Favorite
2:00 PM – 3:30 PM
(4-069) Naloxone & Opioid Overdose Terminology Preferences Among Rural Caregivers: Differences by Race
Favorite
2:00 PM – 3:30 PM
(4-048) Opioid-free Recovery After Inguinal Hernia Repair with Bupivacaine and Meloxicam Extended Release Solution as the Foundation of a Multimodal Analgesia Regimen in a Real-world Setting
Favorite
2:00 PM – 3:30 PM
(4-006) Patient Satisfaction with Point of Care Testing (POCT) for Hemoglobin a1c (HbA1c) at an Academic Medical Center Serving a Rural Population
Favorite
2:00 PM – 3:30 PM
(4-011) Patients Who Require Invasive Procedures While Receiving P2Y12 Inhibitors Incur Greater Healthcare Resource Utilization and Costs
Favorite
2:00 PM – 3:30 PM
(4-074) Pharmacy Integration into the Fertility Service Line: University Hospitals Specialty Pharmacy
Favorite
2:00 PM – 3:30 PM
(4-019) Pharmacy-led transitions of care service to increase empagliflozin prescribing rates in patients with heart failure and/or ischemic stroke at a public urban teaching hospital
Favorite
2:00 PM – 3:30 PM
(4-072) Photoinitiators Including Injection Solution Induce Breast Tumor Growth in Mouse Xenografts with MCF-7 Breast Cancer Cells
Favorite
2:00 PM – 3:30 PM
(4-003) Planning and Relocation of the Pharmacy of a Mother-child University Health Center
Favorite
2:00 PM – 3:30 PM
(4-014) Real-world Risk of Medullary Thyroid Carcinoma with GLP-1 Receptor Agonist Use: A Review
Favorite
2:00 PM – 3:30 PM
(4-017) Reducing Inpatient Intravenous Iron Use in a Community Hospital
Favorite
2:00 PM – 3:30 PM
(4-027) Reversal of anticoagulation in orthogeriatric patients with hip fracture requiring early surgical intervention
Favorite
2:00 PM – 3:30 PM
(4-049) Safely and Effectively Utilizing Opioid Pain Medications in Patients Taking Buprenorphine
Favorite
2:00 PM – 3:30 PM
(4-004) Survey of Hospital Pharmacy Practice in Canada – 1985-86 to 2020-21
Favorite
2:00 PM – 3:30 PM
(4-021) Switching to the Most Cost Effective Infliximab in a County Health System
Favorite
2:00 PM – 3:30 PM
(4-037) Synergistic Activity Evaluation of Aztreonam in Combination with Ceftazidime-avibactam for Treatment of Resistant Stenotrophomonas Maltophilia in Patients with Cystic Fibrosis using a One-compartment Pharmacokinetic Model
Favorite
2:00 PM – 3:30 PM
(4-052) Systematized Review of the Effect of Posture on Drug Pharmacokinetics: Implications for Clinicians and Clinician-scientists in Drug Development
Favorite
2:00 PM – 3:30 PM
(4-024) Targeted Prescriber and Pharmacist Education for Use of 4-factor PCC in Reversal of Anticoagulation in a Community Hospital
Favorite
2:00 PM – 3:30 PM
(4-043) The Efficacy and Safety of gp2013-rituximab: A Rituximab Biosimilar in a Tertiary Care Hospital in Lebanon
Favorite
2:00 PM – 3:30 PM
(4-067) Topical Application of a Vancomycin Paste for Hemostasis During Cardiothoracic Surgery: A Safety Assessment
Favorite
2:00 PM – 3:30 PM
(4-054) Transition of a Pharmacy Compounding Compliance Platform in a Health System: A Descriptive Journey of Sterile, Non-sterile and Unit Inspection Module Implementation
Favorite
2:00 PM – 3:30 PM
(4-039) Use of an Order Set to Promote Institutional Change in the Standard Monitoring Assay for Intravenous Heparin Infusion at an Academic Affiliated Health System
Favorite
2:00 PM – 3:30 PM
(4-070) What Role Do Pharmacists Have in Caring for Patients with Chronic Conditions? Perceptions of Patients with Cardiovascular Disease and Inflammatory Bowel Disease
Favorite
Tuesday, December 6, 2022
2:00 PM – 3:30 PM
(8-133) 20 Years of Pharmacy Practice Research in a Mother-child University Health Center
Favorite
2:00 PM – 3:30 PM
(8-102) Accuracy and Reproducibility of Small Volume Injections from Prefilled “code Cart” Syringes Compared to Standard Polypropylene Syringes
Favorite
2:00 PM – 3:30 PM
(8-140) Allopurinol Induced Neutropenia After Durable Left Ventricular Assist Device (LVAD) Implantation in COVID Positive Patient with Acute Kidney Injury on Renal Replacement Therapy. Case Report
Favorite
2:00 PM – 3:30 PM
(8-134) Annual Audit of the Preparation and Administration of Medication by Nursing Professionals in a Quebec University Hospital Center
Favorite
2:00 PM – 3:30 PM
(8-116) Antithrombin III Utilization Pre- and Post-implementation of a Non-restrictive Hemostatic Protocol
Favorite
2:00 PM – 3:30 PM
(8-096) Assessment of Infliximab Use in Hospitalized Patients
Favorite
2:00 PM – 3:30 PM
(8-122) Bioconjugated nanometals and cancer therapy: a pharmaceutical perspective
Favorite
2:00 PM – 3:30 PM
(8-143) Bringing M-health to the Oncological Patient: A Pharmacy Hospital Approach
Favorite
2:00 PM – 3:30 PM
(8-088) Ceftriaxone-associated Cryptococcoid Sweet Syndrome: A Case Report
Favorite
2:00 PM – 3:30 PM
(8-129) Challenges Faced by Biopharmaceutical Industry Pharmd Fellows and How to Overcome Them
Favorite
2:00 PM – 3:30 PM
(8-123) Comparison of First Order Pharmacokinetic Equation and Bayesian Approach in Estimating Vancomycin AUC in Critically Ill Patients
Favorite
2:00 PM – 3:30 PM
(8-113) Delayed High-dose Methotrexate Clearance with Encephalopathy and Acute Kidney Injury in a Pediatric Patient with Acute Lymphoblastic Leukemia Taking Concomitant Dasatinib: A Case Report
Favorite
2:00 PM – 3:30 PM
(8-136) Development of a Nursing Intervention to Improve HCAHPS Scores in the Medication Domain
Favorite
2:00 PM – 3:30 PM
(8-131) Development of a Unique Approach to Antimicrobial Stewardship at a Stand-alone Inpatient Psychiatric Facility
Favorite
2:00 PM – 3:30 PM
(8-120) Does Left-lateral Decubitus Posture Affect Theophylline Absorption?: Retrospective, Exploratory Analysis of a Prospective, Randomized, Steady-state Study in Stable Adult Asthmatic/copd Patients
Favorite
2:00 PM – 3:30 PM
(8-094) Drug Take Back Days as Part of University Sustainability Initiatives
Favorite
2:00 PM – 3:30 PM
(8-099) Drug Use Evaluation of Sodium Polystyrene Sulfonate in Patients with Hyperkalemia
Favorite
2:00 PM – 3:30 PM
(8-108) Efficacy Data from ECOSPOR III: A Phase 3, Double-blind, Placebo-controlled, Randomized Trial of SER-109, an Investigational Microbiome Therapeutic for Patients with Recurrent Clostridioides difficile Infection
Favorite
2:00 PM – 3:30 PM
(8-075) Evaluating Ibandronate Prescriptions and Targeting Recommendations for Broad-spectrum Bisphosphonates (IbanBSBPs)
Favorite
2:00 PM – 3:30 PM
(8-118) Evaluating the Effectiveness of a Revised Hypoglycemic Protocol Incorporating Glucose Gel in a Community Hospital
Favorite
2:00 PM – 3:30 PM
(8-147) Evaluating the Impact of Gabapentinoid Tolerance, Naivete, on Peri-operative Oxygen Desaturations
Favorite
2:00 PM – 3:30 PM
(8-080) Evaluation of a Hybrid Human-electronic Data Collection Process for Determining Alignment of Periprocedural Anticoagulation Practices at a Rural Medical Center: A Retrospective Quality Improvement Study
Favorite
2:00 PM – 3:30 PM
(8-105) Evaluation of Antibiotic Prescribing Practices upon Hospital Discharge
Favorite
2:00 PM – 3:30 PM
(8-081) Evaluation of High Dose Recombinant Factor Viia for Perioperative Bleeding in Cardiac Surgery Patients
Favorite
2:00 PM – 3:30 PM
(8-077) Evaluation of Pharmacist Co-management of Gender Affirming Hormone Therapy in an Endocrinology Clinic (Access-GAHT)
Favorite
2:00 PM – 3:30 PM
(8-087) Evaluation of Pharmacist Managed Basal-bolus Insulin Dosing in Comparison to Physician Glucose Management in a Community Hospital
Favorite
2:00 PM – 3:30 PM
(8-098) Evaluation of Sugammadex and Neostigmine Use in Neuromuscular Blockade Reversal in the Perioperative Setting at an Academic Medical Center
Favorite
2:00 PM – 3:30 PM
(8-144) Evaluation of Telephonic versus In-person Medication Counseling on Patient Satisfaction
Favorite
2:00 PM – 3:30 PM
(8-092) Evaluation of the Timing of Using Direct Oral Anticoagulants After Ischemic Stroke for Patients with Atrial Fibrillation
Favorite
2:00 PM – 3:30 PM
(8-095) Evaluation of Use of Proton Pump Inhibitors in Community Pharmacies in Different Regions of Lebanon
Favorite
2:00 PM – 3:30 PM
(8-145) Impact of a Clinical Pharmacist in a Mobile Integrated Health / Telemedicine Program for Chronic Obstructive Pulmonary Disease Patients at High Risk for Readmission
Favorite
2:00 PM – 3:30 PM
(8-074) Impact of an Inflammatory Bowel Disease Pharmacist Program in an Outpatient Clinic
Favorite
2:00 PM – 3:30 PM
(8-104) Impact of Electronic Health Record Prescribing Guidance on Carbapenem Usage
Favorite
2:00 PM – 3:30 PM
(8-139) Impact of System Wide Process Improvement Initiative to Avoid Therapeutic Duplication for As-needed Indications
Favorite
2:00 PM – 3:30 PM
(8-137) Implementation of a Patient-centered Discharge Interview Regarding New Medicine Prescribed During Hospitalization at Neurological Ward at Odense University Hospital in Denmark
Favorite
2:00 PM – 3:30 PM
(8-114) Implementation of a Pharmacist Led COVID-19 Pre-exposure Prophylaxis Program in a Community Based Health System Ambulatory Oncology Clinic
Favorite
2:00 PM – 3:30 PM
(8-142) Improvement in Clinical Outcomes and Access to Care with Pharmacist-led Chronic Care Management Services at a Rural Family Medicine Clinic
Favorite
2:00 PM – 3:30 PM
(8-146) Injectable Antipsychotic Efficacy in Schizophrenia and Schizoaffective Disorder: A Mixed Treatment Comparison
Favorite
2:00 PM – 3:30 PM
(8-126) Interprofessional Relationships in Healthcare
Favorite
2:00 PM – 3:30 PM
(8-100) Is there a benefit to having a part time clinical pharmacy specialist in the emergency department?
Favorite
2:00 PM – 3:30 PM
(8-085) Medication Use Evaluation, Education, and Pharmacist Follow up for Improvement in a Clinical Pharmacy Program at a Rural Medical Center
Favorite
2:00 PM – 3:30 PM
(8-068) “Meeting DSCSA Compliance Requirements and Creating Strategic Value – One Health System’s Journey”
Favorite
2:00 PM – 3:30 PM
(8-121) Meropenem Dosing Recommendations in Patients Receiving Home Hemodialysis Using Monte Carlo Simulation
Favorite
2:00 PM – 3:30 PM
(8-135) Monitoring Program of Surface Contamination with 11 Antineoplastic Drugs in 124 Canadian Hospitals
Favorite
2:00 PM – 3:30 PM
(8-107) Monoclonal Antibodies May Reduce Return Visits to the Emergency Department and Hospital Admissions for sars-cov-2
Favorite
2:00 PM – 3:30 PM
(8-103) Mortality Risk and Long-term Complications Associated with Catheter-Related Bloodstream Infections (CRBSIs)
Favorite
2:00 PM – 3:30 PM
(8-091) Multiple Switching Between the Biosimilar Adalimumab PF-06410293 and High Concentration Reference Adalimumab in Combination with Methotrexate in Patients with Moderately to Severely Active Rheumatoid Arthritis
Favorite
2:00 PM – 3:30 PM
(8-071) National Strategies to Optimize Taiwan's Drug Supply Chain and Mitigate Drug Shortages Amid COVID-19 Pandemic
Favorite
2:00 PM – 3:30 PM
(8-090) Once-daily Crisaborole as Long-term Maintenance Treatment to Reduce the Incidence of Flares in Patients with Mild-to-moderate Atopic Dermatitis: A 52-week Clinical Trial
Favorite
2:00 PM – 3:30 PM
(8-112) Optimization of Medication Requests Received via Pneumatic Tube in a Tertiary Hospital
Favorite
2:00 PM – 3:30 PM
(8-130) Out-of-pocket Costs for Long-acting Injectable and Oral Antipsychotics by Low-income Subsidy Status of Medicare Part D Beneficiaries with Schizophrenia
Favorite
2:00 PM – 3:30 PM
(8-084) Perception of Pharmacist’s Role in Optimizing Kidney Health in Patients with Chronic Kidney Disease
Favorite
2:00 PM – 3:30 PM
(8-125) Personality Characteristics and Expressed Career Choices of Third-year Student Pharmacists
Favorite
2:00 PM – 3:30 PM
(8-124) Pharm. D. Experiential Training in Hospitals – a Virtual One-week Training Following COVID19
Favorite
2:00 PM – 3:30 PM
(8-093) Pharmacist-provided Tobacco Treatment Services: Implementation for Reimbursement and Sustainability
Favorite
2:00 PM – 3:30 PM
(8-097) Pharmacoeconomic and Effectiveness Analysis of the Switching from Prophylactic VIII Factor Concentrates to Emicizumab in Pediatric Hemophilia a Patients in a Tertiary Care Hospital
Favorite
2:00 PM – 3:30 PM
(8-110) Quantitative Analysis of Neonatal and Infant Standardized Concentrations Based upon Smart Pump Utilization Data
Favorite
2:00 PM – 3:30 PM
(8-089) Rabeprazole Reverses Pantoprazole/esomeprazole Related ALT/AST Elevating in a HCV Infected Patient
Favorite
2:00 PM – 3:30 PM
(8-076) Real-world Evidence on Effectiveness, Drug Persistence and Safety of Cycling Janus Kinase Inhibitors in Rheumatoid Arthritis
Favorite
2:00 PM – 3:30 PM
(8-086) Reduction of COPD Readmissions in an Acute Care Hospital After Implementation of a Transitions of Care Pharmacy Service
Favorite
2:00 PM – 3:30 PM
(8-111) Research Pharmacy Workflow Changes During Transition to an Electronic Health Record with Computerized Physician Order Entry
Favorite
2:00 PM – 3:30 PM
(8-078) Role of Continuous Glucose Monitoring in the Management of Type II Diabetes Mellitus Patients: A Retrospective Review
Favorite
2:00 PM – 3:30 PM
(8-079) Role of Dopamine D2 Receptor Agonist Prolactin Inhibitor Bromocriptine in Management of Cardiogenic Shock Developed During Childbirth Secondary to Acute Peripartum Cardiomyopathy (PPCM). Case Report
Favorite
2:00 PM – 3:30 PM
(8-138) Safety and Quality Assessment of TPN Delivery When Transitioning from In-house Production to an Outsourcing Admixture Pharmacy
Favorite
2:00 PM – 3:30 PM
(8-115) Sequential Continuing Education Programs Increase Confidence and Knowledge of Pharmacists Managing Iron Deficiency Anemia in Patients with Cancer
Favorite
2:00 PM – 3:30 PM
(8-128) Shifting Comprehensive Mock Residency Interviews to a Fully Remote Format
Favorite
2:00 PM – 3:30 PM
(8-109) Tenofovir Disoproxil Fumarate Switching to Tenofovir Alafenamide for Three Years Resulted Hepatic Fibrosis Improvement by APRI, FIB-4, and Shear Wave Elastography in Hepatitis B Patients
Favorite
2:00 PM – 3:30 PM
(8-073) The Impact of an Intervention on Patients at Risk of Becoming Adherence Outliers Within an Ambulatory Care Pharmacy
Favorite
2:00 PM – 3:30 PM
(8-082) The Impact of the Senior Savings Model (SSM) on Medicare Patients for Key Outcomes Related to Insulin Utilization
Favorite
2:00 PM – 3:30 PM
(8-132) Therapeutic Interchange Cost-savings Initiative: Lisdexamfetamine to Amphetamine/dextroamphetamine ER
Favorite
2:00 PM – 3:30 PM
(8-117) Treatment of a Gastrointestinal Bleed with Subcutaneous Octreotide in a Pediatric Patient
Favorite
2:00 PM – 3:30 PM
(8-127) Trends in Postgraduate Year 2 Pharmacy Residencies from 2008 to 2022
Favorite
2:00 PM – 3:30 PM
(8-072) Two Year Retrospective Comparison of COVID-19 Cases and Drug Expenditure Trends at Five Community Hospitals
Favorite
2:00 PM – 3:30 PM
(8-106) Utilization of Methicillin-resistant Staphylococcus aureus Nasal Swab Polymerase Chain Reaction Assay or Culture to De-escalate Empiric Vancomycin or Linezolid for the Treatment of Pneumonia
Favorite
2:00 PM – 3:30 PM
(8-119) Vancomycin Monitoring in Children Using Bayesian Estimation
Favorite
Back to Top
